Skip to content
Research Article Open access CC BY 4.0

Plasma Thrombopoietin Level in Thrombocytopenic Patients with or without Liver Cirrhosis Chronically Infected by the Hepatitis C Virus

Aiman Al-Qtaitat, Said Al-Dalaen, Samir Mahgoub, Nedal Alnawaiseh, Jehad Al-Shuneiqat, Sameeh Al-Sarayreh, Yousef Al –Saraireh

Journal of Advances in Medicine and Medical Research · pp. 864–871 · Published 10 Oct 2014

10.9734/BJMMR/2015/9860

Abstract

Background and Aim: Thrombocytopenia is a frequent problem in patients with post- hepatitis C (HCV) liver cirrhosis and also occurs in chronic HCV-infected patients without liver cirrhosis. The aim of this study was to evaluate the role of plasma thrombopoietin (TPO) in the occurrence of thrombocytopenia in both conditions. Method: Platelet count and plasma thrombopoietin level and liver function tests were measured in four groups of patients: twenty chronic patients with post-hepatitis C liver cirrhosis and thrombocytopenia (group I), ten chronic HCV-positive patients with liver cirrhosis without thrombocytopenia (group II), ten chronic HCV-positive patients without liver cirrhosis with thrombocytopenia (group III) and chronic ten HCV-positive patients without liver cirrhosis and without thrombocytopenia (group IV). Ten normal healthy individuals were included as a control group. Results: Plasma levels of albumin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), TPO and platelet counts in the four groups of patients were significantly different from their corresponding levels in the control group (P <0.001). There was a significant positive correlation between plasma TPO levels and platelet counts in group III patients (ρ (Spearman's [rho]) = 0.661, P= 0 .038). There was no significant correlation between TPO levels and platelet counts in the other three groups of patients. The logistic regression analysis in the three designated models, using dependent variables (chronic HCV infection, liver cirrhosis and thrombocytopenia) and an independent variable (TPO plasma level) revealed that liver cirrhotic patient and the thrombocytopenic patient have equally the best prediction model for the low plasma TPO. Conclusion: Decreased thrombopoietin production has a role in the pathogenesis of thrombocytopenia in liver cirrhosis.

Thrombopoietin thrombocytopenia liver cirrhosis hepatitis C infection

References (26)

  1. 1 Thrombopoietin: the primary regulator of platelet production [see comments] [DOI]
  2. 2 Thrombocytopenia associated with chronic liver disease [DOI]
  3. 3 Localization and Regulation of Thrombopoietin mRNA Expression in Human Kidney, Liver, Bone Marrow, and Spleen Using In Situ Hybridization [DOI]
  4. 4 Thrombocytopenia associated with hepatitis C viral infection [DOI]
  5. 5 Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis [DOI]
  6. 6 Thrombocytopenia in Liver Disease [DOI]
  7. 7 Thrombopoietin Levels in Patients with Cirrhosis before and after Orthotopic Liver Transplantation [DOI]
  8. 8 Serum Thrombopoietin Levels in Patients With Chronic Hepatitis and Liver Cirrhosis [DOI]
  9. 9 Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation [DOI]
  10. 10 Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease [DOI]
  11. 11 Thrombopoietin: the Primary Regulator of Megakaryocyte and Platelet Production [DOI]
  12. 12 Peripheral blood count abnormalities among patients with hepatitis C in the United States [DOI]
  13. 13 Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis [DOI]
  14. 14 New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura [DOI]
  15. 15 Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
  16. 16 Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag [DOI]
  17. 17 Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis [DOI]
  18. 18 Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system [DOI]
  19. 19 Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
  20. 20 Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: role of thrombopoietin.
  21. 21 Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size.
  22. 22 Does Spleen Volume Play a Role in Patients with HCV-Related Chronic Hepatitis? [DOI]
  23. 23 Interferon increases serum thrombopoietin in patients with chronic hepatitis C [DOI]
  24. 24 Thrombopoietin serum levels do not correlate with thrombocytopenia in hepatic schistosomiasis [DOI]
  25. 25 [The relationship among the counts of platelet, thrombopoietin and spleen index in patients with liver cirrhosis].
  26. 26 GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.

Cited by 2

Article metrics

Real usage data collected on this platform.

67

Page views

0

PDF downloads

23

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.